Form 4 Filing for Misra Veet

This filing details a transaction by Misra Veet, Chief Financial Officer of ASCENTAGE PHARMA GROUP INTERNATIONAL, on April 20, 2026. Veet acquired 18,584 Restricted Stock Units (RSUs) with a transaction value of $0.0. These RSUs vest immediately and represent a contingent right to one Ordinary Share of the Issuer upon vesting. The filing also includes a Power of Attorney document, appointing Thomas J. Knapp and Leslie Brault as attorneys-in-fact to handle SEC filings on behalf of Veet Misra. This power of attorney grants broad authority for executing and filing necessary documents, including Forms 3, 4, and 5, under various securities regulations. It remains in effect until Veet Misra is no longer required to file such documents or until earlier revoked.